arrow_back Civic Audit
Share share

Improved Mental Health Treatment for Medicaid Beneficiaries.

This bill aims to enhance treatment for individuals with depression and other mental health conditions covered by Medicaid. It introduces guidelines for state Medicaid programs to better utilize genetic testing in medication selection, which should reduce trial-and-error in treatment and improve therapeutic outcomes.
Key points
Issuance of guidance for state Medicaid programs on best practices for treating major depressive disorder and other mental health conditions.
Recommendation for using pharmacogenetic testing to better select medications and reduce trial-and-error in treatment.
Improved access to more effective treatment methods for Medicaid beneficiaries with mental health issues.
article Official text account_balance Process page notifications_active Track this Bill
gavel
Status:
Expired
Record your position for audit.
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens (explained here). Start recording it now.
Additional Information
Print number: 117_S_4633
Sponsor: Sen. Brown, Sherrod [D-OH]
Process start date: 2022-07-27
System Note: Lustra is free, publicly auditable civic infrastructure, with full source code available on GitHub. You are reading sterilized legislative data, processed by our radical neutrality engine to strip political spin and retain factual mechanics. We process only official government data. Original documents remain the authoritative source, always verify them if you can.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

A bill to improve outcomes for Medicaid beneficiaries with major depressive disorder or other mental health conditions.

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 117_S_4633.

Which chamber initiated this legislation?

This legislation was initiated in the Senate.

When did the legislative process begin?

The process officially started on 2022-07-27.

What are the main provisions?

Key points include:

  • Issuance of guidance for state Medicaid programs on best practices for treating major depressive disorder and other mental health conditions.
  • Recommendation for using pharmacogenetic testing to better select medications and reduce trial-and-error in treatment.
  • Improved access to more effective treatment methods for Medicaid beneficiaries with mental health issues.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Sen. Brown, Sherrod [D-OH].

What is the latest detailed status?

The latest detailed status is: Introduced in Senate

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-29.

What is the impact of this bill?

We don't know, that is up to you to decide. Summarizing raw data with AI is fundamentally different from predicting socio-economic outcomes. As of 2026, we believe impact assessment strictly requires a human in the loop to verify and judge.

CATEGORIES

Health Benefits